Are You Interested In Investing In Prestige Consumer Healthcare Inc. (PBH)? Check This Out First

0
9
KOSK
KOSK

As of Wednesday close, Prestige Consumer Healthcare Inc.’s (NYSE:PBH) stock was down -$1.1, moving down -1.81 percent to $59.80. The average number of shares traded per day over the past five days has been 243,920 shares. 5 times new highs have been achieved over the past 5 days, with a $1.45 gain in that time frame. In the last twenty days, the average volume was 220,775, while in the previous 50 days, it was 252,800.

Since last month, PBH stock rose 12.77%. Shares of the company fell to $52.00 on 11/03/22, the lowest level in the past month. A 52-week high of $63.47 was reached on 01/05/22 after having rallying from a 52-week low of $48.51. Since the beginning of this year, PBH’s stock price has dropped by -1.40% or -$0.85, and marked a new high 3 times. However, the stock has declined by -5.78% since its 52-week high.


China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored


PBH stock investors should be aware that Prestige Consumer Healthcare Inc. (PBH) stock had its last reported insider trading activity 6 days ago on Nov 18. Lombardi Ronald M., the Chief Executive Officer of the company, disposed of 38,793 shares for $59.10 on Nov 18. It resulted in a $2,292,569 divestment by the insider.

Valuation Metrics

Right now, Prestige Consumer Healthcare Inc. (PBH) has a P/E ratio of about 14.54. The stock’s beta is 0.56. Besides these, the trailing price-to-sales (P/S) ratio of 2.62, the price-to-book (PB) ratio of 1.84, and the price-to-cash flow ratio of 12.25 may also be considered.

Financial Health

In the three months ended June 29, Prestige Consumer Healthcare Inc.’s quick ratio stood at 1.30, while its current ratio was 2.20, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.89, and the total debt-to-equity ratio was 0.89. On the profitability front, the trailing twelve-month gross margin is 56.40% percent. In the year ended June 29, operating margins totaled 29.90%. Based on annual data, PBH earned $620.65 million in gross profit and brought in $1.09 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 8.80%. Return on equity (ROE) for the past 12 months was 13.20%.

In Prestige Consumer Healthcare Inc.’s quarter-end financial report for June 29, it reported total debt of $1.44 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. PBH’s revenue rose 4.51% to $277.06 million during the quarter, while net income inched up to $289.27 million. While analysts expected Prestige Consumer Healthcare Inc. to report $1.04 quarterly earnings, the actual figure was $1.09 per share, beating the consensus estimate by 4.80%. During the quarter, the company generated $93.6 million in EBITDA. The liabilities of Prestige Consumer Healthcare Inc. were 2.06 billion at the end of its most recent quarter ended June 29, and its total debt was $1.5 billion. The value of shareholders’ equity is $49.53 million.

Technical Picture

This quick technical analysis looks at Prestige Consumer Healthcare Inc.’s (PBH) price momentum. With a historical volatility rate of 21.65%, the RSI 9-day stood at 65.65% on 23 November.

With respect to its five-day moving average, the current Prestige Consumer Healthcare Inc. price is up by +2.49% percent or $1.45. At present, PBH shares trade +9.48% above its 20-day simple moving average and +0.03% percent above its 100-day simple moving average. However, the stock is currently trading approximately +16.71% above its SMA50 and +0.12% above its SMA200.

Stochastic coefficient K was 89.95% and Stochastic coefficient D was 92.20%, while ATR was 1.54. Given the Stochastic reading of 81.67% for the 14-day period, the RSI (14) reading has been calculated as 65.64%. As of today, the MACD Oscillator reading stands at 0.99, while the 14-day reading stands at 1.83.

Analyst Ratings

Canaccord Genuity launched its rating on Prestige Consumer Healthcare Inc. (NYSE: PBH) to a Buy in a note to investors on November 17, 2022. Prestige Consumer Healthcare Inc. (PBH) has been rated Buy by analysts. According to 0 brokerage firms, PBH is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Prestige Consumer Healthcare Inc. stock as buy, with 6 recommending it as overweight.

With a median target price of $66.50, the current consensus forecast for the stock is $60.00 – $72.00. Based on these forecasts, analysts predict Prestige Consumer Healthcare Inc. (PBH) will achieve an average price target of $66.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here